← Leaderboards
Henning Willers
Massachusetts General Hospital
$1,528,292
Attributed
$3,056,583
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $753.5K · FY2018–22$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$3,056,583 · 1
By mechanism
U01$3,056,583 · 1
Top collaborators
- Aaron N Hata3 shared
- Cyril Henri Benes2 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Sara Isabel Pai$12,404,338
- Ben Z Stanger$14,778,829
- James W Rocco$3,486,054
- Jamie S Ostroff$23,039,922
- Patrick Thomas Ellinor$17,149,392
Others in their field
Other Emerging Leaders on “Animal Testing”
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$41,541,738
- Gary Fanger · Rise Therapeutics, Llc$20,503,836
- Lynn Briscoe · Leidos Biomedical Research, Inc.$17,211,140
- Sonia Minikel Vallabh · Broad Institute, Inc.$15,007,691
Research focus
Animal TestingAnticancer ResearchAntineoplastic AgentsBaseBiological MarkersBiomarker ValidationBudgetsCancer BurdenCancer CellCancer Cell LineCancer CenterCancer Therapy Evaluation ProgramCandidate MarkerCell LineCellsCessation Of LifeChemoradiationChemotherapyClinicClinical DataClinical DevelopmentClinically RelevantClinical Translation3-Dimensional
Grant awards (5)
High-Throughput Screening and Validation of Molecular Targeted Chemoradiosensitizers$554,744
U01 · FY2022 · CA · contact PI
High-Throughput Screening and Validation of Molecular Targeted Chemoradiosensitizers$753,506
U01 · FY2021 · CA · contact PI
High-Throughput Screening and Validation of Molecular Targeted Chemoradiosensitizers$616,064
U01 · FY2020 · CA · contact PI
High-Throughput Screening and Validation of Molecular Targeted Chemoradiosensitizers$549,080
U01 · FY2019 · CA · contact PI
High-Throughput Screening and Validation of Molecular Targeted Chemoradiosensitizers$583,189
U01 · FY2018 · CA · contact PI